TGFB1 and neoplasm: Treatment with the murine mAb 1D11 (Genzyme Corp., Sanofi) has shown to neutralize all three isoforms of TGF-β, thus suppressing lung metastases in a murine breast tumor model by increasing infiltration and anti-tumor activity of NK cells and T cells at the metastatic site [127].